source
- Cadrenal Therapeutics launches strategic review to explore sale or partnership for its late-stage cardiology pipelineCadrenal Therapeutics, a heart-focused biotech, announced a strategic review of its late-stage cardiology pipeline, seeking to offload assets or the entire company. The board is evaluating options…
- Matchpoint Therapeutics raises $150M Series B to advance oral covalent therapies for autoimmune diseaseMatchpoint Therapeutics announced a $150 million Series B financing round. The round was co-led by Nextech Invest and Norwest, with participation from Sanofi Ventures, Digitalis Ventures, Invus, BB…